Skip to Content

C21 Investments Inc CXXIF

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

1075 West Georgia Street, Suite 820
Vancouver, BC, V6E 3N9, Canada
T +1 604 336-8613
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Oct 31, 2020
Fiscal Year End Jan 31, 2020
Stock Type
Employees 99